Matthew Bachinski, MD
Gastroenterology · Greenwood, SCNPI 1881687093
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 609 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 36 manufacturers reported payments, led by AbbVie at 32.2% of the total.
Across 609 payments — averaging $14.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Johnson & Johnson$938
- Takeda Pharmaceuticals U.S.A., Inc.$473
- Gilead$441
- Pfizer$337
- plus $3K from 30 others
Across 39 payments — averaging $5828.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$165K
- Boehringer Ingelheim$53K
- Boehringer Ingelheim RCV GmbH & Co KG$10K
What the payments were for
- Food & beverage$8,82299%
- Education$1111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 231 | $2,879 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 69 | $1,164 |
| Johnson & Johnson | 59 | $938 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $473 |
| Gilead | 25 | $441 |
| Pfizer | 24 | $337 |
| Sanofi | 16 | $309 |
| Ironwood Pharmaceuticals, Inc | 21 | $291 |
| QOL Medical, LLC | 20 | $289 |
| Merck | 12 | $179 |
| Bristol Myers Squibb | 12 | $176 |
| Nestle Healthcare Nutrition Inc. | 11 | $173 |
| Ardelyx, Inc. | 8 | $152 |
| Aimmune Therapeutics, Inc. | 6 | $113 |
| Phathom Pharmaceuticals, Inc. | 7 | $91 |
| Ipsen Biopharmaceuticals, Inc | 5 | $88 |
| Medtronic | 1 | $82 |
| Intercept Pharmaceuticals, Inc. | 5 | $79 |
| Lilly USA, LLC | 4 | $77 |
| Daiichi Sankyo Inc. | 4 | $65 |
| Ferring Pharmaceuticals Inc. | 4 | $62 |
| Organon | 5 | $61 |
| Amgen | 4 | $61 |
| UCB, Inc. | 4 | $55 |
| Braintree Laboratories, Inc. | 4 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Vivus LLC | 3 | $36 |
| Mauna Kea Technologies, Inc. | 2 | $29 |
| Pharmacosmos Therapeutics Inc. | 2 | $29 |
| Redhill Biopharma Inc. | 2 | $25 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Laborie Medical Technologies Corp. | 1 | $14 |
| Shionogi Inc | 1 | $12 |
| Alfasigma USA, Inc. | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,933 in reported general payments places this provider in the 75th percentile of 259 gastroenterology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 778 | $11,936 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 167 | $10,651 |
| Pantoprazole Sodium | 609 | $7,945 |
| Dexlansoprazole DrDexlansoprazole | 14 | $4,542 |
| Omeprazole | 130 | $2,334 |
| Budesonide DrBudesonide | 12 | $2,331 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 80 | $1,231 |
| LoperamideLoperamide Hcl | 57 | $1,177 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 46 | $871 |
| Esomeprazole Magnesium | 11 | $732 |
| Sucralfate | 49 | $683 |
| Fluconazole | 41 | $664 |
| Metoclopramide Hcl | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Greenwood
- Bryan GreenGreenwood$12K
- Matthew MasonGreenwood$9K
- Erin ForsterCharleston$788K
- Mark DeleggeCharleston$568K
- Nathan ShoresCharleston$217K
- Andre EaddyGreenville$212K
- Alejandro SuarezCharleston$210K
- Veeral OzaGreenville$199K
- Peter CottonCharleston$193K
- Christina BauerGreenville$179K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.